WallStreetZenWallStreetZen

NASDAQ: HCAT
Health Catalyst Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HCAT

Based on 8 analysts offering 12 month price targets for Health Catalyst Inc

Min Forecast
$3.00+27.66%
Avg Forecast
$4.00+70.21%
Max Forecast
$5.00+112.77%

Should I buy or sell HCAT stock?

Based on 8 analysts offering ratings for Health Catalyst Inc.

Buy
Strong Buy
3 analysts 37.5%
Buy
0 analysts 0%
Hold
5 analysts 62.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HCAT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates HCAT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HCAT stock forecasts and price targets.

HCAT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-10-08
Cantor Fitzgerald
Bottom 1%
1
HoldReiterates$4.00+70.21%2025-10-07
Canaccord Genuity
Bottom 1%
1
Strong BuyMaintains$5.00+112.77%2025-08-29
Piper Sandler
Bottom 7%
7
HoldDowngrades$4.00+70.21%2025-08-27

1 of 1

Forecast return on equity

Is HCAT forecast to generate an efficient return?

Company
8.04%
Industry
20.28%
Market
226.77%
HCAT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HCAT forecast to generate an efficient return on assets?

Company
4.55%
Industry
16.74%
HCAT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HCAT earnings per share forecast

What is HCAT's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$0.21
Avg 2 year Forecast
$0.37
Avg 3 year Forecast
$0.50

HCAT revenue forecast

What is HCAT's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$316.5M+0.14%
Avg 2 year Forecast
$307.9M-2.6%
Avg 3 year Forecast
$316.3M+0.09%
HCAT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HCAT revenue growth forecast

How is HCAT forecast to perform vs Health Information Services companies and vs the US market?

Company
-0.29%
Industry
9.65%
Market
25.47%
HCAT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HCAT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HCAT vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HCAT$2.35$4.00+70.21%Buy
LFMD$3.23$9.63+197.99%Strong Buy
CCLD$3.21N/AN/A
BEAT$3.10$6.75+117.74%Strong Buy
EUDA$2.80N/AN/A
View Top Health Information Service Stocks

Health Catalyst Stock Forecast FAQ

Is Health Catalyst Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: HCAT) stock is to Buy HCAT stock.

Out of 8 analysts, 3 (37.5%) are recommending HCAT as a Strong Buy, 0 (0%) are recommending HCAT as a Buy, 5 (62.5%) are recommending HCAT as a Hold, 0 (0%) are recommending HCAT as a Sell, and 0 (0%) are recommending HCAT as a Strong Sell.

If you're new to stock investing, here's how to buy Health Catalyst stock.

What is HCAT's earnings growth forecast for 2025-2027?

(NASDAQ: HCAT) Health Catalyst's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 31.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.4%.

Health Catalyst's earnings in 2025 is -$107,622,000.On average, 13 Wall Street analysts forecast HCAT's earnings for 2025 to be $14,789,828, with the lowest HCAT earnings forecast at $12,476,928, and the highest HCAT earnings forecast at $18,566,857. On average, 13 Wall Street analysts forecast HCAT's earnings for 2026 to be $26,036,038, with the lowest HCAT earnings forecast at $14,556,416, and the highest HCAT earnings forecast at $46,045,805.

In 2027, HCAT is forecast to generate $35,266,419 in earnings, with the lowest earnings forecast at $20,794,880 and the highest earnings forecast at $51,987,200.

What is HCAT's revenue growth forecast for 2025-2027?

(NASDAQ: HCAT) Health Catalyst's forecast annual revenue growth rate of -0.29% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.47%.

Health Catalyst's revenue in 2025 is $316,063,000.On average, 14 Wall Street analysts forecast HCAT's revenue for 2025 to be $22,385,617,477, with the lowest HCAT revenue forecast at $21,480,969,471, and the highest HCAT revenue forecast at $23,134,657,539. On average, 14 Wall Street analysts forecast HCAT's revenue for 2026 to be $21,775,209,948, with the lowest HCAT revenue forecast at $20,656,247,363, and the highest HCAT revenue forecast at $22,837,587,826.

In 2027, HCAT is forecast to generate $22,375,007,845 in revenue, with the lowest revenue forecast at $21,141,461,228 and the highest revenue forecast at $23,743,650,450.

What is HCAT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: HCAT) forecast ROA is 4.55%, which is lower than the forecast US Health Information Services industry average of 16.74%.

What is HCAT's Price Target?

According to 8 Wall Street analysts that have issued a 1 year HCAT price target, the average HCAT price target is $4.00, with the highest HCAT stock price forecast at $5.00 and the lowest HCAT stock price forecast at $3.00.

On average, Wall Street analysts predict that Health Catalyst's share price could reach $4.00 by Nov 11, 2026. The average Health Catalyst stock price prediction forecasts a potential upside of 70.21% from the current HCAT share price of $2.35.

What is HCAT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: HCAT) Health Catalyst's current Earnings Per Share (EPS) is -$1.59. On average, analysts forecast that HCAT's EPS will be $0.21 for 2025, with the lowest EPS forecast at $0.18, and the highest EPS forecast at $0.26. On average, analysts forecast that HCAT's EPS will be $0.37 for 2026, with the lowest EPS forecast at $0.21, and the highest EPS forecast at $0.65. In 2027, HCAT's EPS is forecast to hit $0.50 (min: $0.29, max: $0.74).

What is HCAT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: HCAT) forecast ROE is 8.04%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.